Author Correction: Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study

Sinthuja Pachchek*, Zied Landoulsi, Lukas Pavelka, Claudia Schulte, Elena Buena-Atienza, Caspar Gross, Ann Kathrin Hauser, Dheeraj Reddy Bobbili, Nicolas Casadei, Patrick May*, Rejko Krüger*, Geeta Acharya, Gloria Aguayo, Myriam Alexandre, Muhammad Ali, Wim Ammerlann, Giuseppe Arena, Rudi Balling, Michele Bassis, Roxane BatutuKaty Beaumont, Regina Becker, Camille Bellora, Guy Berchem, Daniela Berg, Alexandre Bisdorff, Ibrahim Boussaad, David Bouvier, Kathrin Brockmann, Jessica Calmes, Lorieza Castillo, Gessica Contesotto, Nancy De Bremaeker, Nico Diederich, Rene Dondelinger, Nancy E. Ramia, Daniela Esteves, Guy Fagherazzi, Jean Yves Ferrand, Katrin Frauenknecht, Manon Gantenbein, Thomas Gasser, Piotr Gawron, Soumyabrata Ghosh, Marijus Giraitis, Enrico Glaab, Martine Goergen, Elisa Gómez De Lope, Jérôme Graas, Anne Marie Hanff, NCER-PD Consortium

*Corresponding author for this work

Research output: Contribution to journal › Erratum / corrigendum / retractions › Academic

Abstract

npj Parkinson’s Disease, published online 23 November 2023 In this article the wrong Table appeared as Table 3.; the Table should have appeared as shown below. The original article has been corrected. The following text that describes data from the previous version of Table 3 has also been removed: “Compared to severe (6.4?±?4.7) and risk (4.4?±?4.9) variant carriers, the mild (1.7?±?1.4) variant carriers show a significantly shorter disease duration (Table 3).” (Table presented.) Features All pathogenic variants (n?=?67) Severe (n?=?21) Mild (n?=?7) Risk (n?=?39) Non carriers (n?=?554) AAA, mean (SD) 66.5 (±10.2) [OR?=?0.31; p?=?0.3977] 65.1 (±10.2) [OR?=?0.08; p?=?0.292] 67.1 (±15.6) [OR?=?0.59; p?=?0.8959] 67.1 (±9.2) [OR?=?0.57; p?=?0.7512] 67.6 (±10.7) Sex, Male n (%) 40 (59.7%) [OR?=?0.71; p?=?0.1912] 13 (61.9%) [OR?=?0.78; p?=?0.5795] 5 (71.4%) [OR?=?1.19; p?=?0.8336] 22 (56.4%) [OR?=?0.62; p?=?0.151] 375 (67.7%) AAO, mean (SD) 61.6 (±11.5) [OR?=?0.35; p?=?0.484] 58.6 (±13.1) [OR?=?0.02; p?=?0.1158] 65.4 (±17.0) [OR?=?16.16; p?=?0.5308] 62.5 (±9.3) [OR?=?0.9; p?=?0.9548] 62.6 (±11.6) AAO < 45, N (%) 8 (11.9%) [OR?=?1.74; p?=?0.1767] 2 (28.6%) [OR?=?5.14; p?=?0.0549] 1 (2.6%) [OR?=?0.34; p?=?0.2907] 40 (7.2%) Disease Duration, mean (SD) 4.7 (±4.8) [OR?=?0.79; p?=?0.7303] 6.4 (±4.7) [OR?=?4.07; p?=?0.2238] 1.7 (±1.4) [OR?=?0.04; p?=0.0981] 4.4 (±4.9) [OR?=?0.57; p?=?0.5103] 5.0 (±5.2) Family History, N (%) 8 (38.1%) [OR?=?1.8; p?=?0.2001] 2 (28.6% [OR?=?1.17; p?=?0.8508] 15 (38.5%) [OR?=?1.83; p?=?0.0782] 141 (25.5%).
Original languageEnglish
Article number168
Number of pages1
Journalnpj Parkinson's Disease
Volume9
Issue number1
DOIs
Publication statusPublished - 18 Dec 2023

Access to Document

  • Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study

    Pachchek, S., Landoulsi, Z., Pavelka, L., Schulte, C., Buena-Atienza, E., Gross, C., Hauser, A. K., Reddy Bobbili, D., Casadei, N., May, P., Krüger, R., Acharya, G., Aguayo, G., Alexandre, M., Ali, M., Ammerlann, W., Arena, G., Balling, R., Bassis, M., Batutu, R., & 31 othersBeaumont, K., Becker, R., Bellora, C., Berchem, G., Berg, D., Bisdorff, A., Boussaad, I., Bouvier, D., Brockmann, K., Calmes, J., Castillo, L., Contesotto, G., De Bremaeker, N., Diederich, N., Dondelinger, R., E. Ramia, N., Esteves, D., Fagherazzi, G., Ferrand, J. Y., Frauenknecht, K., Gantenbein, M., Gasser, T., Gawron, P., Ghosh, S., Giraitis, M., Glaab, E., Goergen, M., Gómez De Lope, E., Graas, J., Hanff, A. M. & NCER-PD Consortium, 23 Nov 2023, In: npj Parkinson's Disease. 9, 1, 14 p., 156.

    Research output: Contribution to journal › Article › Academic › peer-review

    Open Access

Cite this